NMC Health Plc Board Change (2874V)
05 April 2019 - 7:49PM
UK Regulatory
TIDMNMC
RNS Number : 2874V
NMC Health Plc
05 April 2019
5 April 2019
NMC Health plc
(the "Company" or "NMC")
Board Change
NMC Health plc (LSE: NMC), the leading private healthcare
operator in the Gulf Cooperation Council (GCC) with international
services across 19 countries, today announces the appointment of Mr
Tarek Alnabulsi as an Independent Non-Executive Director of the
Company. Mr Alnabulsi's appointment is effective from 5 April
2019.
Tarek Alnabulsi is an entrepreneur who has founded and
co-founded a number of businesses in Saudi Arabia, UAE and USA
having had more than 20 years of Executive roles with leading and
diversified Groups in the Middle East. He is also an adviser to
family businesses on governance, investments and business
strategies.
Previously, Mr Alnabulsi was a Non-Executive Director and
Chairman of the Audit committee of United Assurance Company, a
leading insurance company listed on Tadawul in Saudi Arabia, and on
the Board of a number of other prominent companies in Saudi Arabia
and UAE, including Injazat Technology Fund, Ebayanat and Arabian
Entertainment Company.
Tarek Alnabulsi was appointed by the Board following a search
undertaken by an external recruitment consultancy. The search,
overseen by the Nominations Committee on the Board's behalf,
specifically focused on bringing additional expertise from the
Kingdom of Saudi Arabia to the NMC Health plc Board given the
Company's expansion plans into the Kingdom.
There is no additional information in respect of Mr Alnabulsi
which is required to be notified for the purposes of Listing Rule
9.6.13.
Mark Tompkins, Joint Non-Executive Chairman of NMC Health
commented:
'We welcome Tarek Alnabulsi to the NMC Health plc Board. As part
of our search requirements, the Nominations Committee focussed on
expertise and experience of Saudi Arabia as a key criteria for our
search given the Company's expansion plans into the Kingdom. We are
delighted that Tarek has agreed to join our Board and we look
forward to his guidance as part of our future strategic
decisions.
Enquiries:
NMC Health plc
H. J. Mark Tompkins
Non-Executive Joint Chairman +44 (0)203 205 7313
Media:
FTI Consulting, London
Brett Pollard / Victoria Foster
Mitchell +44 (0)20 3727 1000
FTI Consulting, Gulf
Shane Dolan +971 (0)4 437 2100
About NMC Health
NMC the leading private healthcare operator in the GCC with an
international network of hospitals across 19 countries. NMC also
ranks as one of the top three in-vitro fertilisation ("IVF")
operators globally. The Group is also a leading provider of
long-term medical care in the UAE through its subsidiary ProVita.
Pursing an aggressive international expansion program from 2016,
NMC has identified the Kingdom of Saudi Arabia (KSA) in particular
as a key growth market, where the company has introduced long-term
and multi-specialty care services. NMC received over 7.5m patients
in 2018. The Group is also a leading UAE supplier of products and
consumables across several key market segments, with the major
contribution coming from healthcare related products. The Group
reported revenues of US$2.1 billion for the year ended 31 December
2018.
In April 2012 NMC was listed on the Premium Segment of the
London Stock Exchange. NMC is a constituent of the FTSE 100
Index.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
BOAGIGDSRSGBGCU
(END) Dow Jones Newswires
April 05, 2019 04:49 ET (08:49 GMT)
Nmc Health (LSE:NMC)
Historical Stock Chart
From Apr 2024 to May 2024
Nmc Health (LSE:NMC)
Historical Stock Chart
From May 2023 to May 2024